- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06240702
Effects of Early Telerehabilitation in Coronary Artery Bypass Surgery Patients
February 11, 2024 updated by: Muammer Corum, Necmettin Erbakan University
The Effect of Early Cardiopulmonary Telerehabilitation on Exercise Capacity, Cardiac Function, Quality of Life and Emotional Status in Coronary Bypass Surgery Patients
The aim of this study was to investigate the effects of phase I and early phase II rehabilitation with telerehabilitation method and sleep hygiene training on physical capacity, cardiac functions, anxiety level, quality of life and sleep quality in patients undergoing coronary artery bypass graft surgery.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Coronary artery disease is one of the most important diseases affecting quality of life in recent years.
Coronary artery bypass graft surgery (CABGC), one of the methods used in the treatment of this disease, is widely accepted as a common operation.
However, both the surgical intervention and the cardiac and pulmonary complications caused by coronary artery disease, such as decreased physical capacity, decreased quality of life and sleep quality, and restriction in functional activities make it difficult to return to pre-disease level.
Today, it is a scientific fact that cardiac and pulmonary rehabilitation applied at the earliest period following surgical treatment reduces the risk of mortality and morbidity, prevents complications and facilitates return to daily life.
In fact, it is now a necessity to evaluate and treat patients comprehensively in many aspects such as nutrition, sleep quality and psychological status with a holistic approach.
Today, applications that bring together healthcare personnel and patients in a virtual environment such as telemedicine, telerehabilitation and mobile-health, which have been widely used in different medical and health fields, especially after the coronavirus-19 pandemic, have gained importance.
Telerehabilitation has advantages in different fields such as neurological, orthopedic, cardiac and pulmonary rehabilitation, such as the ability of the physiotherapist to follow the patient remotely, to apply the rehabilitation program, and to be accessible at any time.
In addition, it is stated in the literature that it has mitigating effects on the patient's dependency and health costs, such as eliminating the need for the patient to travel to the center and reducing the need for caregivers.
When the literature is examined, it is seen that there are few cardiac and pulmonary rehabilitation applied with telerehabilitation method in the postoperative period in coronary artery bypass graft surgery patients.
In addition, there is no study in the literature examining the effect of sleep hygiene training in addition to telerehabilitation on these patients.
Therefore, this study aimed to contribute to the literature as an original study by examining the effects of cardiopulmonary rehabilitation and sleep hygiene training applied for 4 weeks with the telerehabilitation method, which is a current approach, on patients who underwent coronary artery bypass graft surgery.
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Muammer Corum, M.Sc.
- Phone Number: 0905433781877
- Email: muammercorum@gmail.com
Study Contact Backup
- Name: Hanife Dogan, Assoc. Prof.
- Phone Number: 905075346142
- Email: hanife_dogan@yahoo.com.tr
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Participants who are class 2-3 according to the New York Heart Association (NYHA)
- Participants had an ejection fraction >40%
- If the participant has had a myocardial infarction (MI), 7 days have passed since the MI
- Low-medium risk group patients as a result of Euroscore evaluation (0-2 low risk, 3-5 medium risk, 6< high)
- Patients with adequate cognition-perception level (Mini mental test score of 24 and above)
- Individuals who are not diagnosed with sleep disorders for any reason
- Having the knowledge to make video calls with a smart phone
- Declaring that you wish to participate in the study with written consent
Exclusion Criteria:
- Aneurysm history
- Patients with advanced left ventricular dyskinesia
- Patients with neurological orthopedic comorbid diseases
- Presence of any defect in the rib cage
- Patients with Chronic Obstructive Pulmonary Disease (COPD)
- Patients hospitalized for a long time (6 months and more)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Telerehabilitation Group
Patients in the experimental group will be included in the face-to-face Phase I rehabilitation program until discharge and in the Phase II telerehabilitation program and sleep hygiene training for 3 weeks after discharge.
Respiratory exercises will be performed as part of the phase I rehabilitation program until the patients are discharged.
In addition, active range of motion and mobility exercises in bed, sitting position and standing, increasing distance walking and stair ascent and descent training will be provided.
During the sessions, the patient's vital signs and clinical status will be monitored with a finger pulse oximeter and a blood pressure measuring device according to the patient's perceived degree of difficulty (Borg Scale).
As part of the Phase II telerehabilitation program, respiratory exercises, calisthenic exercises and gait training will be performed.
|
Unlike the control group, the experimental group will be given a phase II telerehabilitation program and sleep hygiene training for 3 weeks after discharge.
Within the scope of the Phase II telerehabilitation program, breathing exercises and calisthenic exercises will be performed at increasing intensity according to the patient's tolerance, 3 days a week for 3 weeks.
In addition, walking training will be continued over increasing distances.
In addition, it will be aimed to increase sleep quality by giving a sleep hygiene education brochure to the patients in the experimental group.
During the sessions, the vital signs and clinical status of the patients will be monitored according to the severity level determined by the finger pulse oximeter device, digital blood pressure monitor, perceived difficulty level (Borg Scale) and maximum heart rate.
In addition, patients will be kept in a diary to monitor their compliance with the treatment program.
|
No Intervention: Control Group
Patients in the control group will be included in the face-to-face Phase I rehabilitation program until discharge and no intervention will be made after discharge.
Until the patients in the control group are discharged, respiratory exercises will be performed as in the experimental group within the scope of the phase I rehabilitation program.
In addition, active range of motion and mobility exercises in bed, sitting position and standing, increasing distance walking and stair ascent and descent training will be provided.
During the sessions, the patient's vital signs and clinical status will be monitored with a finger pulse oximeter and a blood pressure measuring device according to the patient's perceived degree of difficulty (Borg Scale).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
6 minute walk test (6MWT)
Time Frame: four weeks
|
The test is performed in a closed area, on a flat surface 30 meters long (every 3 meters is marked), under the supervision of a physiotherapist.
Dyspnea and fatigue of the patients are questioned during the 6MWT and the values before and after the test are recorded.
At the end of 6 minutes, the total distance walked by the patient is recorded in meters.
Studies have shown that a 6-minute walking distance of less than 350 meters is a predictor of mortality in cardiopulmonary diseases.
|
four weeks
|
Duke Activity Status Scale
Time Frame: four weeks
|
This 12-question index helps to calculate the metabolic equivalent of task (MET) used in daily life. 1 MET represents the resting Oxygen consumption of a 40-year-old 70 kg person at rest, which is normally 3.5 ml/kg/min.
According to this index; self-care, eating, dressing, going to the toilet, short walks inside the house, short walks outside, light housework, between 1-4 METs; climbing hills or stairs, fast walking, short jogging, heavier work at home, light sports, between 4-10 METs; Heavy sports such as swimming, tennis are evaluated above 10 METs.
The approximate values obtained according to the answers to the questions asked are classified as follows; Excellent if >7 MET 4-7 MET is Moderate <4 MET indicates a poor or uncertain prognosis.
|
four weeks
|
State Trait Anxiety Inventory
Time Frame: four weeks
|
The Turkish version of the State Trait Anxiety Inventory (STAI) will be used to assess the anxiety level of the subjects.
The STAI consists of 2 parts, the state anxiety scale and the trait anxiety scale, and a total of 40 questions.
When answering the state anxiety scale, patients are asked to select one of the options 'not at all', 'a little', 'a lot' and 'completely' according to the severity of the feelings, thoughts and behaviors expressed by the items; when answering the trait anxiety scale, patients are asked to mark one of the options 'almost never', 'sometimes', 'most of the time' and 'almost always' according to the frequency of the feelings, thoughts and behaviors expressed by the items.
High scores indicate a high level of anxiety.
Turkish validity and reliability studies have been conducted.
|
four weeks
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: four weeks
|
PSQI was adapted into Turkish by Agargun et al. (1996).
PSQI evaluates sleep quality in the last month.
19 of the total 24 questions included in PSQI are self-report questions. 5 questions are answered by the spouse or a roommate.
The last 5 questions mentioned are used only for clinical information and are not included in the scoring.
The 18 items included in the scoring are grouped into 7 component scores.
Some of the components are specified with a single item, while others are obtained by grouping several items.
Each item is evaluated on a scale of 0-3 points.
The sum of the 7 component scores gives the total PSQI score.
The total score has a value between 0-21.
A high total score indicates poor sleep quality.
|
four weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Echocardiography
Time Frame: four weeks
|
The term echocardiography covers all imaging techniques in which the heart is examined with ultrasound, such as pulsed and continuous wave Doppler, color Doppler and tissue Doppler imaging (TDI: tissue doppler imaging).
Echocardiography is an easily accessible, non-invasive, rapid and safe method that provides comprehensive information on cardiac anatomy (volumes, geometry, mass), wall motion and valve function.
|
four weeks
|
Left Ventricular Dysfunction Scale (LVD-36)
Time Frame: four weeks
|
The Left Ventricular Dysfunction (LVD-36) Scale was developed by O'Leary and Jones (2000) to measure the effect of left ventricular dysfunction on daily life and well-being in patients with heart failure.
This scale; It consists of a total of 36 statements asked to determine the problems caused by heart disease.
Statements are presented to patients with two options: true or false.
The correct answers given are added up and the total number of correct answers is expressed as a percentage.
Scores from the scale are between "0-100", with "100 points" taken from the scale being considered the worst score and "0 points" being considered the best score.
As the score of the scale increases, the quality of life decreases.
The Turkish validity and reliability study of the LVD-36 scale was conducted by Özer and Argon (2005).
|
four weeks
|
Minnesota Living With Heart Failure Questionnaire
Time Frame: four weeks
|
It is a quality of life survey consisting of 21 questions and two dimensions (physical and emotional sub-dimensions) specific to Heart Failure patients.
It was designed by Thomas Rector in 1984 to measure the impact of heart failure and its treatment on an individual's quality of life.
The survey was prepared in Likert type.
The survey assesses the impact of common physical symptoms such as shortness of breath, fatigue, peripheral edema, symptoms of anxiety and depression.
In addition, it aims to measure the effects of physical and social functioning in heart failure.
The lowest score that can be obtained from the scale is 5 and the highest score is 105.
The Turkish adaptation was made by Uzunhasanoglu in 2013.
|
four weeks
|
Modified Medical Research Council Dyspnea Scale
Time Frame: four weeks
|
The scale used to evaluate patients' shortness of breath classifies it from stage 1 to stage 5 to determine the severity of shortness of breath.
|
four weeks
|
Hand Grip Strength Assessment
Time Frame: four weeks
|
Upper extremity muscle strength will be evaluated with a hand dynamometer.
It has been reported that hand grip strength is not only correlated with upper extremity muscle strength, but also with general body muscle strength and pulmonary muscle strength.
Test; It will be made in the sitting position, which is the standard position recommended by the American Association of Hand Therapists, with the shoulder in adduction and neutral rotation, the elbow in 90° flexion, the forearm in middle rotation, and the wrist in neutral.
Three measurements will be made, the average will be taken and recorded as kg/F.
In addition, pinch grip strength will be measured in the same way with a pinch meter type dynamometer.
|
four weeks
|
30-second sit-to-stand test
Time Frame: four weeks
|
This test reflects the strength of the lower extremities.
The individual sits on the middle part of the chair, which has no armrests and a sitting height of 43.18 cm, with his back upright and straight, his arms crossed in front, and his feet flat on the floor.
It stands up and sits down fully upon the start command.
Count the number of times he stands up fully in 30 seconds.
|
four weeks
|
Body Weight
Time Frame: four weeks
|
Participants' body weight will be recorded as demographic data in kg unit.
|
four weeks
|
Body height
Time Frame: four weeks
|
The height of the participants will be recorded as demographic data in meters unit.
|
four weeks
|
Body Mass Index
Time Frame: four weeks
|
Participants' body mass index will be recorded as demographic data in kg/m² unit.
|
four weeks
|
Heart Rate
Time Frame: four weeks
|
Participants' heart rates before and after the intervention will be recorded in beats/minute.
|
four weeks
|
Blood Pressure
Time Frame: four weeks
|
The blood pressure of the participants before and after the intervention will be recorded in mmHg.
|
four weeks
|
Respiratory Frequency
Time Frame: four weeks
|
The respiratory frequency of the participants before and after the intervention will be recorded as breaths/minute.
|
four weeks
|
Oxygen Saturation
Time Frame: four weeks
|
The oxygen saturation of the participants before and after the intervention will be recorded as SaO₂(%).
|
four weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Hanife Dogan, Assoc. Prof., Necmettin Erbakan University Faculty Member
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
April 20, 2024
Primary Completion (Estimated)
August 20, 2024
Study Completion (Estimated)
January 31, 2025
Study Registration Dates
First Submitted
January 26, 2024
First Submitted That Met QC Criteria
January 26, 2024
First Posted (Actual)
February 5, 2024
Study Record Updates
Last Update Posted (Actual)
February 13, 2024
Last Update Submitted That Met QC Criteria
February 11, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NEU-SSHMYO-FP-MC-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
-
San Luigi Gonzaga HospitalRecruitingCoronary Disease | STEMI | Coronary Artery Ectasia | Right Coronary Artery Occlusion | Right Coronary Artery StenosisSpain, Italy
Clinical Trials on Telerehabilitation Group
-
Marmara UniversityEnrolling by invitationHemiparetic Cerebral PalsyTurkey
-
Bright Cloud International CorpNational Cancer Institute (NCI); Rutgers, The State University of New JerseyRecruitingCognitive Impairment, MildUnited States
-
Muğla Sıtkı Koçman UniversityCompleted
-
Gazi UniversityCumhuriyet UniversityRecruiting
-
Universidad de GranadaCarlos III Health InstituteCompleted
-
Hasan Kalyoncu UniversityCompleted
-
University of Eastern FinlandOulu University Hospital; Kuopio University HospitalRecruiting
-
Bahçeşehir UniversityCompleted
-
Hasan Kalyoncu UniversityCompletedBruxism | Myofascial Pain | Temporomandibular DisorderTurkey